Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Spearheading the Future of Healthcare Through Technology, Innovation and Support for Pharmacists

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is a pharmacy service innovator committed to acquiring and developing early-stage technologies that seek to grow and push pharmacy forward. Since its inception, this Vancouver-based enterprise has stayed true to its mission to become the world’s largest health data company. This is evidenced by its move to innovate and leverage specific point-of-care technologies within its community of pharmacies. Avricore’s flagship platform, HealthTab(TM), impacts the healthcare sector mainly by simplifying patients’ lives with easy access to point-of-care testing. With HealthTab, Avricore can offer pharmacies complete turnkey and point-of-care rapid testing systems covering both… Read More>> NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com [email protected]

InvestorWire is part of the InvestorBrandNetwork.